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AbstrAct
Peroxisome proliferator activated receptor α (PPARα) stimulates hepatocellular 
proliferation is species-specific. Activation of mouse, but not human, PPARα induces 
hepatocellular proliferation, hepatomegaly, and liver cancer. Here we tested the 
hypothesis that human and mouse PPARα affects liver regeneration differentially. 
PPARα-humanized mice (hPPARαPAC) were similar to wild type mice in responding to 
fasting-induced PPARα signaling. However, these mouse livers failed to regenerate in 
response to partial hepatectomy (PH). The liver-to-body weight ratios did not recover 
even 3 months after PH in hPPARαPAC. The mouse PPARα-mediated down-regulation 
of let-7c was absent in hPPARαPAC, which might partially be responsible for impaired 
proliferation. After PH, hPPARαPAC displayed steatosis, necrosis, and inflammation 
mainly in periportal zone 1, which suggested bile-induced toxicity. Quantification 
of hepatic bile acids (BA) revealed BA overload with increased hydrophobic BA in 
hPPARαPAC. Forced FGF21 expression in partial hepatectomized hPPARαPAC reduced 
hepatic steatosis, prevented focal necrosis, and restored liver mass. Compared to 
mouse PPARα, human PPARα has a reduced capacity to regulate metabolic pathways 
required for liver regeneration. In addition, FGF21 can compensate for the reduced 
ability of human PPARα in stimulating liver regeneration, which suggests the potential 
application of FGF21 in promoting hepatic growth in injured and steatotic livers in 
humans.
INtrODUctION
Active metabolism is required to generate energy 
and precursors for the biosynthesis of macromolecules 
used to produce cell or tissue mass to fully execute liver 
regeneration [1, 2]. A transient steatosis was noted in early 
phases of liver regeneration, and when this is disrupted, a 
delay in liver regeneration is noted, indicating that rapid 
accumulation of intracellular triglycerides may provide 
a crucial energy substrate for the regenerating liver [3]. 
Conversely, excessive accumulation of hepatic lipids is 
also linked to impaired liver regeneration, as demonstrated 
in humans as well as genetically-modified mouse models 
of obesity [4, 5]. Thus, lipid homeostasis plays a role in 
modulating liver regeneration. 
Due to the important function of peroxisome 
proliferator-activated receptors (PPAR) in regulating 
lipid homeostasis, the effects of PPARα, β, and γ on liver 
regeneration have been studied. Notably, PPARβ regulates 
liver regeneration by modulating AKT and E2f signaling 
with PPARβ deficiency delaying normal liver regeneration 
in mice [1]. Disruption of hepatic PPARγ expression in 
mice with diet-induced hepatic steatosis resulted in 
significant suppression of liver regeneration [2]. Lack of 
PPARα also delays liver regeneration through suppression 
of cell cycle control, cytokine signaling, fat metabolism, 
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and impaired Ras signaling [6, 7]. 
PPARα regulates not only lipid metabolism, but 
also cell proliferation, the latter of which is rodent 
specific [8]. Sustained activation of PPARα induces 
hepatocyte proliferation and hepatocellular carcinomas 
in rodents [8]. However, humans are not susceptible to 
the hepatocarcinogenic effects of PPARα agonists [8, 9]. 
It is unknown whether there exists a species difference 
in hepatocyte proliferation during liver regeneration. 
Although the strong hepatocyte proliferative effect 
of rodent PPARα causes liver cancer, such effective 
proliferative effect may be beneficial for liver regeneration. 
Thus, the current study examined the species-specific 
role of PPARα in liver regeneration by performing a 2/3 
partial hepatectomy (PH) in wild-type (WT) and PPARα-
humanized (hPPARαPAC) mice. 
PPARα-regulated pathways could be important in 
the control of liver regeneration. For example, PPARα 
is a key regulator of hepatic fatty acid metabolism and 
can be activated by hypolipidemic drugs. Thus, activation 
of PPARα signaling in hepatic steatotic patients prior to 
liver transplantation could potentially be beneficial [10]. 
Stimulation of PPARα induces expression of fibroblast 
growth factor 21 (Fgf21), which encodes a cytokine 
essential for hepatic lipid oxidation and ketogenesis 
in the adaptive response to fasting conditions [11]. 
Administration of FGF21 exerts beneficial effects 
including reduction of adiposity, insulin resistance, 
dyslipidemia, and fatty liver [12, 13]. FGF21 has an 
effect in preventing lipopolysaccharide, acetaminophen, 
cerulein, and dioxin-induced toxicity and injury [11, 
14-16]. Thus, it seems that PPARα-activated-FGF21 
may have a role in repairing an injured liver. PPARα 
also regulates inflammatory pathways [10]. The IL-6-
mediated STAT3 activation signaling, which is crucial for 
liver regeneration, is compromised in PPARα knockout 
mice [6]. Moreover, PPARα has a role in bile acid (BA) 
homeostasis [10]. Circulating blood BA levels increase 
after PH, and depletion of BAs decrease regeneration [17]. 
After PH, the remnant liver is exposed to a high flux of 
BAs, and regulation of BA homeostasis is essential for 
the normal progression of liver regeneration in rodents 
[17, 18]. In addition, lack of the BA receptor farnesoid 
x receptor (FXR) delays liver regeneration [17]. In 
humans, hepatocyte proliferation is commonly observed in 
biopsies of cholestatic livers [19]. Thus, PPARα-regulated 
pathways including fatty acid and BA homeostasis as well 
as inflammatory signaling modulate liver regeneration. 
However, it is unknown whether there is a species 
difference in those PPARα-regulated pathways during 
liver regeneration. The current study used hPPARαPAC to 
compare the role of human and mouse PPARα in response 
to PH-induced liver regeneration.
rEsULts
Overnight fasting activates PPARα target genes in 
both WT and hPPARαPAc mice
Fasting activates PPARα downstream pathways 
in the mouse liver resulting in increased fatty acid 
catabolism [11]. Thus, hPPARαPAC mice were subjected to 
fasting to determine whether the fasting-induced PPARα 
signaling activation is conserved with the human receptor. 
Overnight-fasting induced mRNAs encoded by the 
PPARα target genes Fgf21, HMG-CoA synthase (Hmgcs) 
1 and 2, acyl-CoA oxidase 1 (Acox1), cytochrome P450 
4a10 (Cyp4a10), Cyp4a14, peroxisome proliferator-
activated receptor co-activator protein 1α (Pgc1a), and 
phosphoenolpyruvate carboxykinase (Pepck) in WT mice 
(Fig. 1). Fasting induced higher Fgf21 (18 vs. 9.8) and 
lower Hmgcs1 (2.8 vs.4.3), Cyp4a10 (12 vs. 27), and 
Cyp4a14 (17 vs. 61) mRNA levels in hPPARαPAC than in 
WT mice, while fasting-induced Hmgcs2, Acox1, Pgc1a, 
and Pepck mRNA levels were comparable in the two 
mouse lines. These data indicate that human PPARα has 
a functional response to fasting, which is consistent with 
published findings [8].
Reduced liver growth in hPPARαPAc mice after 
PH
PH was performed in WT and hPPARαPAC mice, and 
livers were collected on 1 day up to 3 months post-surgery. 
The liver-to-body weight ratio of WT and hPPARαPAC mice 
Figure 1: Fasting activates mouse and human PPARα 
target genes. Wild type (WT) and PPARα-humanized 
(hPPARαPAC) mice were fasted overnight to activate PPARα 
signaling. The expression of hepatic PPARα target genes was 
studied by qPCR. Fasting induced all the PPARα target genes 
including Fgf21, Hmgcs1 and 2, Acox1, Cyp4a10, Cyp4a14, 
Pgc1a, and Pepck in both WT and hPPARαPAC mice. All values 
represent mean ± standard deviation, n = 5; * p<0.05, student’s 
t test.
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(without surgery) ranged from 4.2-4.5% and no statistical 
difference was found between the groups (data not 
shown). After PH, the liver-to-body weight ratio restored 
within 7 days in WT mice, whereas in hPPARαPAC mice, 
the liver-to-body weight ratios were reduced at all studied 
time points compared to WT controls. The liver-to-body 
weight ratio was 3.6% from 7 days to 3 months after PH in 
hPPARαPAC mice indicating that these mice failed to restore 
their original liver mass and normal liver regeneration was 
disrupted (Fig. 2A). WT livers, compared with hPPARαPAC 
livers, exhibited greater hepatocellular proliferation, as 
shown by increased numbers of Ki67-positive hepatocytes 
after PH (Fig. 2B). Hematoxylin and eosin (H&E) staining 
revealed transient accumulation of hepatic lipids in WT 
mice 1.5 days after PH, which is likely essential for liver 
regeneration [3]. Two days after PH, lipid accumulation 
was diminished in WT livers (Fig. 2C). Representative 
images of hPPARαPAC liver sections harvested 1.5 and 
2 days post-PH indicate that hPPARαPAC mice had lipid 
deposition (Fig. 2C). hPPARαPAC mice also showed 3 to 
7-fold increase in hepatic triglyceride levels 1.5 and 2 
days after PH (Fig. 2C). Furthermore, the increased cell 
proliferation found in WT mice 1.5-2 day after PH were 
accompanied by higher expression levels of proliferating 
cell nuclear antigen (Pcna), Cyclin A, Cyclin B/Cyclin-
dependent kinase (Cdk) 1 complex, Cyclin D/Cdk6 
complex, and Cyclin E mRNAs (Fig. 3A-G). However, 
such inductions were delayed and reduced in hPPARαPAC 
mouse livers. Moreover, Western blots indicated that 
CYCLIN D and E proteins were induced after PH in WT 
mouse livers, but not in hPPARαPAC livers (Fig. 3H). In 
addition, the expression of PPARα target let-7c, which 
promotes cell cycle arrest by targeting c-Myc mRNA [20], 
was studied to compare the differences between mouse 
and human PPARα in regulating liver regeneration. A 
temporal pattern of down-regulated let-7c was observed in 
regenerating WT mice. At most studied time points, except 
3 days after PH, let-7c levels were higher in hPPARαPAC 
Figure 2: PH-induced liver growth is suppressed in hPPARαPAc mice. Wild type (WT) and PPARα-humanized (hPPARαPAC) 
mice were subjected to PH and killed 0 day to 3 months after surgery. Liver-to-body weight ratios were recorded. The data indicated that 
liver regeneration was not completed in hPPARαPAC mice 3 months after the surgery (A). Representative Ki67 staining (10×) of mouse 
livers after PH. The number of proliferative cells was significantly less in hPPARαPAC than WT mice (B). Representative images of H&E 
staining (40×) of liver sections of mice that received PH indicated that hPPARαPAC mice had fat deposition. Hepatic triglyceride levels 1.5 
and 2 days after PH indicated elevated triglyceride in hPPARαPAC livers after PH (C). All values represent mean ± standard deviation, n = 
5; * p<0.05, student’s t test.
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than WT mouse livers (Fig. 4A). Accordingly, c-Myc 
mRNA levels were lower in hPPARαPAC than WT mouse 
livers 1, 2, and 5 days after PH (Fig. 4B).
Diminished FGF21 expression and its downstream 
lipid homeostasis target genes in hPPARαPAc 
mouse livers after PH 
FGF21 plays a key role in regulating fatty acid 
oxidation, triglyceride clearance, and ketogenesis in the 
liver [11]. Fgf21 mRNA level was induced and peaked in 
WT mice 1 day after PH. In contrast, Fgf21 mRNA was 
not detected in hPPARαPAC mouse livers after PH (Fig. 
5A). Consistent finding was noted at the protein level (Fig. 
5B). In addition, the induction of CYP4A14 protein was 
observed in WT mice, but not detectable in hPPARαPAC 
livers after PH (Fig. 3B). Moreover, the binding of PPARα 
in the promoter region of the Fgf21 gene was enriched in 
WT mouse regenerating livers, but not in hPPARαPAC mice 
as demonstrated by ChIP-qPCR (Fig. 5C). FGF21 induces 
PGC1α and its target genes in response to starvation [21]. 
To further assess the role of FGF21 in liver regeneration, 
the expression of FGF21 target genes involved in lipid 
homeostasis (Pgc1a, Acox1, Cpt1, Cyp4a14, Cyp4a10, 
Pepck) was studied (Fig. 5D-I). In WT mice, the induction 
of these mRNAs correlated with the observed induction 
of Fgf21 mRNA 1 day post-PH. There was no induction 
of the aforementioned genes in hPPARαPAC livers up to 
7 days after PH. Cyp4a10 and Cyp4a14 mRNA was not 
detectable in hPPARαPAC mouse livers.
Liver pathology
hPPARαPAC mouse livers had pathological features 
of vacuolation and focal necrosis 3 hours post-PH. 
Steatosis, dilate bile duct, dilated lymphatic, and duct 
metaplasia with periportal fibrosis were noted 2 days after 
PH. Interface hepatitis where lymphocytes invaded from 
the portal tract and mild steatohepatitis were notice from 7 
days and 3 months post-PH (Fig. 6). These morphological 
features indicated zone 1 periportal injury. The post-
PH injury observed in hPPARαPAC mice suggested bile-
induced toxicity [18], thus, hepatic BAs were quantified. 
Figure 3: The induction of hepatic cell cycle genes is diminished in hPPARαPAc mice after PH. Experiments were performed 
based on the description in Figure legend 2. Hepatic gene expression of Pcna, Cyclin A, Cyclin B/Cdk1, Cyclin D/Cdk6, and Cyclin E was 
studied by qPCR in WT and hPPARαPAC mouse livers after PH (A-G). Western blot analysis of CYCLIN D and E protein levels in WT and 
hPPARαPAC livers after PH (H). All values represent mean ± standard deviation, n = 5; * p<0.05, student’s t test.
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Figure 4: Hepatic expression levels of let-7c mirNA and c-Myc mRNA in WT and hPPARαPAc mice after PH. Experiments 
were performed based on the description in Figure legend 2. The expression of let-7c (A) and c-Myc (B) was studied by qPCR. A significantly 
higher expression of let-7c was found in hPPARαPAC mice at basal level compared with that in WT mice. After PH, the expression of let-7c 
decreased in both genotypes of mice. However, the decreased levels were significantly less in hPPARαPAC than WT mice in most studied 
time points. Accordingly, higher induction of c-Myc mRNA at day 1, 2, and 5 was found in WT than hPPARαPAC livers. All values represent 
mean ± standard deviation, n = 5; * p<0.05, student’s t test.
Figure 5: The induction of PPARα target FGF21 is diminished in PPARα-humanized mice after PH. Experiments were 
performed based on the description in Figure legend 2. PH was performed in WT and hPPARαPAC mice and hepatic gene expression of 
Fgf21 was studied using qPCR (A). Western blot analysis indicated that FGF21 protein level peaked 1 day after PH in WT livers, but not in 
hPPARαPAC. The induction of CYP4A14 was found in WT mice after PH, but such induction was absent in hPPARαPAC livers after PH (B). 
Chromatin immunoprecipitation assays were performed using liver tissues (n=3) from WT and hPPARαPAC mice 0 and 1 day after PH with 
either PPARα or negative control IgG. The purified DNA fragments were amplified using primers specific for the Fgf21 promoter (C). PH 
was performed in WT and hPPARαPAC mice and hepatic gene expression of Pgc1a, Acox, Cpt1, Cyp4a10, Cyp4a14 and Pepck were studied 
using qPCR (D-I). All values represent mean ± standard deviation, n = 5; * p<0.05, student’s t test.
Figure 6: Liver injury in regenerating hPPARαPAc mice. Experiments were performed based on the description in Figure legend 
2. Representative images of H&E staining (10×) of liver sections of mice that received PH indicated that WT had normal histology 
post-surgery, but regenerating hPPARαPAC mice had zone 1 periportal injury. Focal necrosis indicated by yellow arrows; dilated bile duct 
indicated by red arrows; dilated lymphatic indicated by black arrows; interface hepatitis indicated by green arrows. Inserts show liver injury 
in greater detail including vacuolation and focal necrosis of hepatocytes (3 hours, 40×), periportal fibrosis (Masson’s trichrome staining, 
10×, 2 days), and interface hepatitis (3 months, 40×) in hPPARαPAC mice. 
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It is important to note that the injury was not due 
to surgery itself because none of WT mice had liver 
pathology after the surgery.
Quantification of hepatic BA and study the 
expression of genes regulate bA homeostasis
The basal hepatic total bile acid (TBA) level 
was similar between WT and hPPARαPAC mice, but the 
composition of BA was different (Fig. 7A, B). The levels 
of primary BAs including CA, CDCA, MCA, UDCA were 
higher in WT than hPPARαPAC mice (Fig. 7A). After PH, 
TBA level was transiently increased within 3 hours of PH 
and returned to the basal level 1 day later (Fig. 7B). In 
contrast to WT mice, sustained increase in TBA was noted 
in hPPARαPAC mice post-PH (Fig. 7B). The ratio of CA to 
CDCA, frequently found to be higher in patients who have 
inflammation or cholestasis [22,23], was calculated during 
liver regeneration in both genotypes. The CA/CDCA ratio 
substantially increased in regenerating hPPARαPAC mice 
(Fig. 7C). The MCA/CA ratio was lower in hPPARαPAC 
than WT mice also suggested increased hydrophobicity 
after PH in hPPARαPAC mice (Fig. 7D) [18]. The increased 
ratio of TCA to TCDCA, which has been implicated in 
CCl4-induced acute liver injury in mice [24], was also 
calculated, and the ratio was higher in hPPARαPAC than 
WT mice 1, 2, 3, and 7 days post-PH (Fig. 7E). 
The expressions of genes encoding proteins that 
regulate BA homeostasis were then examined. Before 
PH, hPPARαPAC mice had higher mRNA levels of solute 
carrier family 10 member 1 (Ntcp), and organic solute 
transporter beta (Ostb), but similar mRNA levels of Bsep 
and Cyp7a1/8b1/27a1, as compared to WT mice (Fig. 8A-
C). In addition, small heterodimer partner (Shp) mRNA 
level was more than two folds higher in hPPARαPAC mice 
compared to WT mice (data not shown). After PH, the 
mRNA levels of Cyp7a1/8b1/27a1 were suppressed in 
both genotypes. However the mRNA levels of Cyp7a1/8b1 
were barely detectable in hPPARαPAC 1-2 day after PH 
(Fig. 8A, B). The mRNA levels of Ntcp and Bsep showed 
similar expression profile in both genotypes, but levels 
were lower in hPPARαPAC than WT mice 2 days post-PH 
(Fig. 8D-E). Moreover, Ostb mRNA level was robustly 
induced by 62-127 fold in hPPARαPAC mice compared with 
2-7 fold induction in WT mice post-PH (Fig. 8F). 
Figure 7: Dysregulated bile acid homeostasis in regenerating hPPARαPAc mice. Experiments were performed based on the 
description in Figure legend 2. Quantification of individual hepatic BAs in WT and hPPARαPAC before surgery (A), and calculated TBA, 
CA/CDCA, MCA/CA, and TCA/TCDCA ratios from livers that received PH on the basis of mass spectrometry analysis (B-E). All values 
represent mean ± standard deviation, n = 5.
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Dysregulation of inflammatory and fibrotic genes 
in hPPARαPAc livers after PH
Inflammatory signaling and fibrotic response were 
studied due to the occurring pathology in hPPARαPAC mice. 
The nuclear factor erythroid 2-related factor (Nrf2) was 
studied for its protective function against oxidative stress. 
During normal liver regeneration, Nrf2 was induced and 
peaked 2 days after PH in WT mice. The induction of Nrf2 
was absent in hPPARαPAC mice during the first 2 days after 
PH, indicating impaired regulation of anti-oxidative stress 
by human PPARα (Fig. 9A). Pro-inflammatory genes 
including interleukin 6 (Il-6), and membrane cofactor 
protein 1 (Mcp1) were highly induced in hPPARαPAC mice 
1.5 days post-PH in comparison with WT counterparts 
(Fig. 9B-C). The expression levels of cytokeratin-19 
(Ck19), which typically expressed in hepatobiliary tracts, 
were minimally changed in WT, but markedly elevated 
in the hPPARαPAC mice post-PH. The expression levels 
of fibrosis marker α-smooth muscle actin (αSma) and 
collagen type I, α 1 (Col1a1) also showed higher induction 
in hPPARαPAC than WT mice after PH (Fig. 9E-F). 
Figure 9: The expression profiles of hepatic genes. Experiment was performed based on the description in Figure legend 2. Hepatic 
gene expression of Nrf2, IL-6, MCP1, CK19, αSma and Col1a1 were studied using real-time PCR in regenerating WT and hPPARαPAC 
mouse livers (A-F). All values represent mean ± standard deviation, n = 5; * p<0.05, student’s t test.
Figure 8: Dysregulated expression of genes involved in bile acid homeostasis in regenerating hPPARαPAc mice. 
Experiments were performed based on the description in Figure legend 2. Hepatic gene expression of Cyp7a1, Cyp8b1, Cyp27a1, Ntcp, 
Bsep, and Ostb, were studied using real-time PCR in regenerating WT and hPPARαPAC mouse livers (A-F). All values represent mean ± 
standard deviation, n = 5; * p<0.05, student’s t test.
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Adenoviral Fgf21 infusion rescues liver 
regeneration in hPPARαPAc mice
In response to fasting, the induction of FGF21 
was greater in hPPARαPAC than WT mice (Fig. 1). 
However, in response to liver resection, FGF21 mRNA 
and protein (Fig. 5) and its downstream targets that 
regulate lipid homeostasis (Fig. 5) were not induced in 
hPPARαPAC mouse livers. These differences point to 
potential species differences in human and mouse PPARα 
signaling on the FGF21 metabolic pathway in the context 
of liver regeneration. An adenoviral vector expressing 
mouse Fgf21 (Ad-Fgf21) was used to express FGF21 
in hPPARαPAC mouse livers. This construct produced 
significant expression of FGF21 protein within 1 day 
after the injection (Fig. 10A). hPPARαPAC mice infused 
with FGF21 had similar liver-to-body weight ratios as 
the WT mice during the course of liver regeneration (Fig. 
10B). In addition, Ad-Fgf21-injected hPPARαPAC mice 
no longer had steatosis and focal necrosis (Fig. 10C-D). 
Moreover, they displayed increased expression of Fgf21, 
which was sustained 7 days post-pH (Fig. 11A). Forced 
FGF21 expression also restored the Let-7c/c-Myc pathway 
1-2 days post-PH in hPPARαPAC mouse livers (Fig. 11B, 
C). In addition, expression of FGF21 in hPPARαPAC mice 
led to the coordinated up-regulation of Cyclin A, Cyclin 
B/Cdk1 complex, Cyclin E, and Cyclin D/Cdk6 complex 
(Fig. 11D-I). 
Forced FGF21 expression reduced the mRNA levels 
of Tnfa, Il-6, and Mcp1 in hPPARαPAC mouse livers that 
had PH (Fig. 12). Consistent with the phenotype, forced 
FGF21 expression also induced the expression of Pgc1a, 
Cpt1, Cyp4a10, Cyp4a14, and Pepck genes suggesting 
normalization of lipid homeostasis in hPPARαPAC mice 
(Fig. 13). BA quantification showed normalized hepatic 
TBA, MCA/CA, CA/CDCA, and TCA/TCDCA values in 
hPPARαPAC mouse livers with Ad-Fgf21infusion (Fig. 14).
DIscUssION
The current study demonstrated that hPPARαPAC 
mice exhibit reduced hepatocyte proliferative capability 
during liver regeneration in comparison with WT mice. 
The presented data showed that human PPARα-mediated 
signaling that controls liver regeneration was less effective 
than that of mouse PPARα. PH caused persistent steatosis, 
inflammation, and necrosis, which was associated with 
dysregulated lipid and BA homeostasis in hPPARαPAC mice. 
Thus, in response to liver regeneration, hPPARα is not as 
effective as mouse PPARα in regulating lipid metabolism 
as well as hepatocyte proliferation. Metabolism, which is 
mainly controlled by the liver, is about 7 times faster in 
mice than humans [25]. Liver regeneration, which can be 
completed within 7-10 days in mice, takes about 60-90 
days to complete in humans [26]. Thus, it seems that the 
metabolic rate and proliferative capability are correlated, 
and that the species difference of PPARα may account 
for such difference. Because overexpression of FGF21 
could restore the normal progression of liver regeneration 
in hPPARαPAC mice, FGF21 appears to not only repair 
injury, but also compensate for the reduced ability of 
human PPARα to hasten liver regeneration. These findings 
suggest that FGF21 infusion would be of therapeutic value 
to improve the outcome of liver transplantation and liver 
disease in humans. 
The hPPARαPAC mice used in the current study were 
generated with a P1 phage artificial chromosome clone 
containing the complete human PPARα gene including the 
5’ and 3’ flanking sequences [8]. Thus, the strategy used 
allowed the WT and hPPARαPAC mice to have the same 
PPARα tissue distribution pattern, and the levels of PPARα 
are comparable in liver, brown adipose tissue, kidney, 
heart, intestine, lung, etc. [8]. Moreover, hPPARαPAC and 
WT mice respond to fasting as well as fenofibrate in a 
similar manner, which include peroxisome proliferation, 
reduction of serum triglycerides, and induction of genes 
encoding enzymes involved in fatty acid metabolism in 
liver, kidney, and heart. Thus, the observed difference 
was not due to differential tissue distribution pattern or 
difference in expression level. 
Published data suggested that the species difference 
of PPARα might be due to human livers having 10-fold 
lower PPARα expression level compared to mouse livers 
[27]. However, others showed that the level of PPARα 
mRNA was similar between human and mouse livers as 
well as primary hepatocytes [28]. It is important to note 
that PPARα is regulated by the circadian cycle [29]. Thus, 
it is difficult to compare the expression level of PPARα in 
human livers without knowing the time of liver harvesting 
and the expression at the protein level. Microarray data 
showed that activation of PPARα regulates a mostly 
divergent set of genes in mouse and human hepatocytes 
although the key role of PPARα as the master regulator 
of hepatic lipid metabolism is generally well-conserved 
between mouse and human [8]. Consistently, the data 
presented in current study showed that PPARα target 
genes, such as Fgf21, can be induced to different levels 
depending on the challenges and species. In response to 
fasting, human PPARα-induced Fgf21 was higher than 
mouse PPARα, whereas in response to liver resection, 
human PPARα was not able to induce Fgf21 at all. The 
binding data indicated that the lack of induction of FGF21 
was associated with lack of PPARα binding to the Fgf21 
gene in hPPARαPAC mice after PH. Such differences might 
be due to the presence of different endogenous ligands, 
which have different binding affinity to human and mouse 
PPARα, in response to the specific challenges. 
FGF21 is a hepatokine that acts as a global 
starvation signal. As a key metabolic regulator, FGF21 
controls glucose and lipid homeostasis [30-33]. 
Therapeutic administration of recombinant FGF21 exerts 
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Figure 10: Adenoviral delivery of Fgf21 reversed the impaired liver regeneration in hPPARαPAc mice. Adenovirus-
mediated expression of FGF21 in hPPARαPAC mouse livers was accomplished via tail vein injection of Ad-Fgf21 or control vector (Ad-
Control) followed by PH surgery. Western blot analysis revealed restoration of FGF21 protein levels in hPPARαPAC mice was similar to 
that in WT (A). Liver-to-body weight ratios were recorded (B). Representative images of hPPARαPAC livers with Ad-control or Ad-Fgf21 
injection harvested 2 and 7 days after PH (C). Representative images of H&E staining (10×) of hPPARαPAC liver sections with and without 
Ad-Fgf21 injection harvested 2 and 7 days after PH (D). All values represent mean ± standard deviation, n = 5; * p<0.05, student’s t test, 
hPPARαPAC with Ad-control vs WT with Ad-Control.
Figure 11: Adenoviral delivery of Fgf21 reversed the impaired cell cycle gene expressions in regenerating hPPARαPAc 
mice. Experiment was performed based on the description in Figure legend 10. Hepatic gene expression of Fgf21, let-7c, c-Myc, and cell 
cycle genes including Cyclin A, B, D, E as well as Cdk1, and Cdk6 were studied using real-time PCR in regenerating WT mice, hPPARαPAC 
mice, and hPPARαPAC mice with Ad-Fgf21 injection (A-I). All values represent mean ± standard deviation, n = 5; * p<0.05, student’s t test, 
hPPARαPAC with Ad-Fgf21 vs WT with Ad-Control.
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Figure 12: Adenoviral delivery of Fgf21 reversed the dysregulated expression of genes that are involved in pro-
inflammation in regenerating hPPARαPAc mice. Experiment was performed based on the description in Figure legend 10. Hepatic 
gene expression of pro-inflammation genes (Tnfα, Il-6, Mcp1) were studied using real-time PCR in regenerating WT mice and hPPARαPAC 
mice with Ad-Control, and hPPARαPAC mice with Ad-Fgf21 injection (A-C). All values represent mean ± standard deviation, n = 5; * 
p<0.05, student’s t test, hPPARαPAC with Ad-Fgf21 vs WT with Ad-Control.
Figure 13: Adenoviral delivery of Fgf21 reversed the dysregulated expression of genes that are involved in lipid 
homeostasis in regenerating hPPARαPAc mice. Experiment was performed based on the description in Figure legend 10. Hepatic 
gene expression of PPARα target genes involved in lipid homeostasis (Pgc1a, Cpt1, Cyp4a10, Cyp4a14, Pepck) were studied using real-
time PCR in regenerating WT mice and hPPARαPAC mice with Ad-Control, and hPPARαPAC mice with Ad-Fgf21 injection (A-E). All values 
represent mean ± standard deviation, n = 5; * p<0.05, student’s t test, hPPARαPAC with Ad-Fgf21 vs WT with Ad-Control.
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a variety of beneficial effects in rodents and nonhuman 
primates, including reduction of adiposity and alleviation 
of hyperglycemia, insulin resistance, dyslipidemia, and 
fatty liver disease [21]. FGF21 deficiency increases the 
susceptibility of mice to cerulein-induced pancreatitis and 
toxicity of sepsis, as well as acetaminophen-induced liver 
injury, suggesting a potentially protective effect of FGF21 
against acute organ injury [11,14-16]. Replenishment of 
FGF21 protects acute liver failure from acetaminophen-
inducted hepatic ROS accumulation and reverses the 
abolishment of antioxidant gene expression by increasing 
PGC1α [16]. FGF21 regulates energy homeostasis through 
activation of AMPK and SIRT1 in mice [34]. SIRT1 is 
implicated in liver regeneration by regulating bile acid 
metabolism [35]. Published data suggested that FGF21 
regulates AMPK through interaction with between 
ERK1/2 and LKB1 [34], and LKB1/AMPK activation 
plays a critical role in controlling Cyclin D and Cyclin A 
expression [36]. Moreover, ERK1/2 signaling promotes 
cell proliferation by regulating cell cycle progression 
during liver regeneration in mice [37]. FGF21 may 
regulate liver regeneration through these pathways. 
Additional studies are needed to understand the role of 
FGF21 in tissue repair and liver regeneration. In addition 
to PPARα, FGF21 can be regulated by other nuclear 
receptors that include the bile acid receptor FXR, retinoic 
acid receptor, and receptor-related orphan receptor α [30-
33]. It is also possible that these nuclear receptor-mediated 
signaling pathways were altered in hPPARαPAC mice after 
PH, a possibility that needs to be explored.
One distinct difference between human and mouse 
PPARα is their proliferative effect. Fenofibrate induces 
hepatocyte proliferation in WT mice, but not in hPPARαPAC 
mice, and a differential regulation of oncogenic let-7c by 
PPARα accounts for the species difference in proliferation 
[20]. Let-7c is markedly reduced in highly proliferative 
cancer cells and overexpression of let-7c inhibits cancer 
cell growth [20]. Let-7c repression is mouse PPARα-
dependent [20]. Notably, mouse, but not human, PPARα 
up-regulates c-Myc-induced cell cycle gene expression 
through let-7c inhibition [20]. The expression of let-7c 
levels is reduced 2 hours after PH in rat, suggesting that 
let-7c repression is essential for cell cycle genes induction 
[38]. The diminished inhibition of let-7c and reduced cell 
cycle gene expressions in regenerating hPPARαPAC mouse 
livers support the view that an inherent difference exists 
between mouse and human PPARα in regulating cell 
proliferation. Forced expression of FGF21 normalized 
the expression pattern of let-7c and c-Myc 1-2 days post-
PH in hPPARαPAC mouse livers. The relationship between 
FGF21-regulated metabolism and let-7c/c-Myc-regulated 
cell proliferation remains to be established. 
PPARα is a major regulator of BA synthesis [39], 
and high BAs were persistently present in regenerating 
hPPARαPAC livers. In contrast, WT mice only had a 
modest and transient increase in hepatic TBA after PH. 
Dysregulated BA homeostasis was likely the direct cause 
of liver injury because sustained BA dysregulation was 
Figure 14: Adenoviral delivery of Fgf21 reversed the dysregulated bile acid homeostasis in regenerating hPPARαPAc 
mice. Experiment was performed based on the description in Figure legend 10. Quantification of TBA, CA/CDCA, MCA/CA, and TCA/
TCDCA ratio from livers that received PH on the basis of mass spectrometry analysis (A-D). All values represent mean ± standard deviation, 
n = 5; * p<0.05, student’s t test, hPPARαPAC with Ad-Fgf21 vs WT with Ad-Control.
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found in regenerating hPPARαPAC mouse livers, which 
have hepatic injury focused around the periportal area. 
In addition, the composition of BAs was altered with 
increased hydrophobicity found in hPPARαPAC mice. Fine-
tuning BA levels is essential during liver regeneration 
to protect hepatocytes from BA-induced toxicity while 
allowing sufficient BA signaling to stimulate regeneration 
[17, 18]. PPARα activation in regulating CYP7A1 and 
BA homeostasis is controversial. Stimulation of PPARα 
by fibrates represses mRNA levels and enzyme activity 
of human CYP7A1, whereas activation of PPARα 
induces mouse Cyp7a1 transcriptional activity [39]. 
The differential regulation of the Cyp7a1 by PPARα in 
humans and mice could be a novel species-specific effect. 
The basal levels of Cyp7a1/8b1/27a1 expression were 
similar in both genotypes of mice. However, liver injury 
and inflammation can inhibit Cyp7a1 gene expression 
[40], which might in part responsible for reduced 
Cyp7a1 expression in hPPARαPAC mouse livers after 
PH. Ostb mRNA is relatively abundant in human liver, 
but not in mouse liver and expression of Ostb is mainly 
positively regulated by BAs via the FXR [41]. Enhanced 
hepatic Ostb mRNA and protein is found in patients who 
have primary biliary cirrhosis and in animal model of 
cholestasis [41]. Induction of Ostb increases bile salt flux 
and reduces the accumulation of intracellular bile salts 
[42]. A dramatic induction of Ostb mRNA in hPPARαPAC 
livers after PH suggested increased bile salt burden 
post-surgery. Enhanced BA levels which resulted from 
dysregulated expression of genes involved in BA synthesis 
and transport could also account for periportal pathology 
found in hPPARαPAC livers after PH. 
In conclusion, liver regeneration is impaired in 
hPPARαPAC mice, which may be partially due to an over-
accumulation of lipids and BA. Compared to murine 
PPARα, human PPARα is ineffective in regulating 
lipid and BA metabolism in response to PH. However, 
forced expression of FGF21 can reverse this deleterious 
condition and restore normal liver regeneration programs 
in hPPARαPAC mice. This finding indicates the importance 
of FGF21 in liver regeneration and suggests its potential 
application in promoting hepatic growth in injured and 
steatotic livers in humans.
MAtErIALs AND MEtHODs
Animal
Male WT and hPPARαPAC mice [8] were used 
for this study. The hPPARαPAC mice, on a Ppara-null 
background, express the human PPARα gene, and were 
characterized previously [8]. Mice, 3- to 5-month-old 
were housed in steel microisolator cages at 22°C with a 
12-hr light/dark cycle. Food and water were provided ad 
libitum throughout the study with the exception of fasting 
experiments. Standard 2/3 PH was performed using the 
procedure described previously [1, 43, 44]. Mice were 
killed 3 hours, 1, 1.5, 2, 3, 5, 7 days and 1, 3 months 
after PH. At least 5 mice were used to study each time 
point. The liver and body weights at the time of death 
were recorded to calculate liver-to-body weight ratios. 
The results obtained were the mean of at least five mice 
per studied time point. A section of each liver sample was 
fixed in 10% formalin, embedded in paraffin, and stained 
for histological analysis. All animal experiments were 
conducted in accordance with the National Institutes of 
Health Guide for the Care and Use of Laboratory Animals 
under protocols approved by the Institutional Animal Care 
and Use Committee of the University of California, Davis.
Ki67 immunostaining
Immunostaining with anti-Ki67 antibody 
(NeoMarkers, Fremont, CA) was performed to monitor 
cell proliferation. The number of Ki67-labeled cells was 
counted in six microscopic fields (10X) for each section.
Western blot. Liver protein (40 µg) was 
electrophoresed on SDS-polyacrylamide gels. Proteins 
from the gels were transferred to the polyvinylidene 
fluoride membranes. Anti-FGF21, CYCLIN D, CYCLIN 
E, CYP4A14, and β-actin (Santa Cruz, CA) antibodies 
were used for detection of proteins. 
real-time quantitative polymerase chain reaction 
(qPcr)
Hepatic RNA isolated using TRIzol (Invitrogen, 
CA) was reverse transcribed to generate cDNA followed 
by amplification using the ABI Prism 7900HT sequence 
detection system (Applied Biosystems, CA). Hepatic 
mRNA levels were normalized based on hepatic Gapdh 
mRNA levels. 
Bile acid quantification
Methanol, water, and formic acid, all of LC/MS 
grade, were purchased from Fisher Scientific (Santa Clara, 
CA). CA, DCA, CDCA, UDCA, LCA, glycol and tauro 
derivatives were purchased from Steraloid Inc. (Newport, 
RI). Sample preparation was performed based on published 
methods [45]. The detection of hepatic BAs was carried 
out on a ProminenceTM UFLC system (Shimadzu, Kyoto) 
coupled to an API 4000 QTRAPTM mass spectrometer 
(AB Sciex, CA) operated in the negative ionization mode. 
Chromatography was performed on a Kinetex C
18
 column 
(50 mm X 2.1 mm, 2.6 μm) maintained at 40°C preceded 
by a high pressure column prefilter. The mobile phase 
consisted of gradient of methanol delivered at a flow 
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rate of 0.4 ml/min. MS parameters were described in our 
previous publication [46]. 
Forced expression of FGF21 using recombinant 
adenovirus
Recombinant adenovirus expressing mouse FGF21 
was purchased from Vector BioLabs (Vector Biolabs, PA). 
The adenoviral vector was transfected into a mammalian 
HEK293T cells to produce large-scale adenovirus [30]. 
Expression of FGF21 was achieved via tail vein injection 
[47]. Each mouse received 7.5 x 109 particles/g body 
weight of Ad-Fgf21 or Ad-Control plasmid in 0.1 ml of 
saline before PH surgery [47]. 
chromatin immunoprecipitation (chIP) Pcr 
assays
ChIP assays were performed based on previous 
studies [48, 49]. Briefly, chromatin lysates were cleared 
before incubation with a ChIP-quality anti-PPARα 
antibody (Santa Cruz Biotechnology, Santa Cruz, CA). 
Antibodies to IgG (Santa Cruz Biotechnology, Santa Cruz, 
CA) and RNA Polymerase II (Millipore, Billerica, MA) 
were used as negative and positive controls, respectively. 
Samples were incubated with Dynase beads at 4ºC 
overnight followed by de-crosslinking and purification. 
DNA fragments generated served as templates for Real-
Time PCR using Power SYBR Green PCR Master Mix.
statistical Analysis
Data are given as mean ± SD. Statistical analysis 
was performed using Student’s t test or one-way analysis 
of variance. Significance was defined by p < 0.05.
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